Daily Archives: March 14, 2018

Arcus Biosciences Prices 8 Mln Shares at $15/Share

Arcus Biosciences, a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, disclosed late Wednesday the pricing of its initial public offering of 8 million shares at $15.00 per share for total gross proceeds of $120 million.
Read more